LUCAS CAPITAL MANAGEMENT - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 86 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2014. The put-call ratio across all filers is 1.76 and the average weighting 1.0%.

Quarter-by-quarter ownership
LUCAS CAPITAL MANAGEMENT ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q3 2015$37,000
-21.3%
21,1000.0%0.02%0.0%
Q2 2015$47,000
+14.6%
21,1000.0%0.02%
+23.5%
Q1 2015$41,000
-26.8%
21,1000.0%0.02%
-19.0%
Q4 2014$56,000
-8.2%
21,100
+5.0%
0.02%
+10.5%
Q3 2014$61,000
-23.8%
20,100
+2.6%
0.02%
-24.0%
Q2 2014$80,0000.0%19,600
+5.4%
0.02%
-3.8%
Q1 2014$80,000
-17.5%
18,6000.0%0.03%
-18.8%
Q4 2013$97,00018,6000.03%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q4 2014
NameSharesValueWeighting ↓
CAXTON CORP 21,704,847$5,209,0007.19%
CAXTON CORP 67,000$16,0000.02%
McQueen, Ball & Associates Inc. 102,742$25,0000.02%
TWO SIGMA SECURITIES, LLC 36,056$9,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,398,330$336,0000.01%
WEDBUSH SECURITIES INC 45,000$11,0000.00%
Roundview Capital LLC 21,100$5,0000.00%
Renaissance Technologies 2,332,995$560,0000.00%
PANAGORA ASSET MANAGEMENT INC 618,599$148,0000.00%
Virtu KCG Holdings LLC 107,071$26,0000.00%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders